Cargando…

Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience

OBJECTIVES: To report overall survival and local control for patients identified in the RSSearch® Patient Registry with metastatic cancer to the lung treated with SBRT. METHODS: Seven hundred two patients were identified with lung metastases in the RSSearch® Registry. Of these patients, 577 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricco, Anthony, Davis, Joanne, Rate, William, Yang, Jun, Perry, David, Pablo, John, D‘Ambrosio, David, Sharma, Sanjeev, Sundararaman, Srinath, Kolker, James, Creach, Kimberly M., Lanciano, Rachelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286804/ https://www.ncbi.nlm.nih.gov/pubmed/28143558 http://dx.doi.org/10.1186/s13014-017-0773-4

Ejemplares similares

Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry
por: Mahadevan, Anand, et al.
Publicado: (2018)

The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy
por: Davis, Joanne N, et al.
Publicado: (2013)

Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry
por: Davis, Joanne N., et al.
Publicado: (2015)

Salvage Stereotactic Body Radiation Therapy for Locally Recurrent Previously Irradiated Head and Neck Squamous Cell Carcinoma: An Analysis from the RSSearch® Registry
por: Ansinelli, Hayden, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy for Clinically Localized Prostate Cancer: Toxicity and Biochemical Disease-Free Outcomes from a Multi-Institutional Patient Registry
por: Davis, Joanne, et al.
Publicado: (2015)

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
por: Davis, Joanne N., et al.
Publicado: (2015)

Propensity Score Matched Comparison of Intensity Modulated Radiation Therapy vs Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Survival Analysis from the National Cancer Database
por: Ricco, Anthony, et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy for Patients with Heavily Pretreated Liver Metastases and Liver Tumors
por: Lanciano, Rachelle, et al.
Publicado: (2012)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2023)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases
por: Spencer, Katie L, et al.
Publicado: (2019)

Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses
por: Patel, Nisha R., et al.
Publicado: (2014)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups
por: Ricco, Anthony, et al.
Publicado: (2016)

Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation Therapy
por: Hasan, Shaakir, et al.
Publicado: (2016)

Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience
por: Hasan, Shaakir, et al.
Publicado: (2015)

Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
por: Berkovic, Patrick, et al.
Publicado: (2020)

Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experience With Long-Term Follow-Up
por: Ricco, Anthony, et al.
Publicado: (2020)

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
por: Lindsay, Adam D., et al.
Publicado: (2018)

Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
por: Gutiérrez, Enrique, et al.
Publicado: (2021)

Simple immobilization for stereotactic radiotherapy aimed at pelvic metastases
por: Janssen, Jorinde, et al.
Publicado: (2023)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
por: Calderon, Benoît, et al.
Publicado: (2023)

Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations
por: Ricco, Anthony, et al.
Publicado: (2020)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
por: Layer, Julian P., et al.
Publicado: (2023)

Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patients
por: Celejewska, Agata, et al.
Publicado: (2014)

Improving accuracy for stereotactic body radiotherapy treatments of spinal metastases
por: Rijken, James, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases
por: Lindberg, Sara, et al.
Publicado: (2022)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting
por: Heal, Cory, et al.
Publicado: (2015)

Single Institutional Experience of Stereotactic Radiosurgery Alone for First Brain Metastatic Event and Salvage of Second Brain Metastatic Event in a Community Setting with Review of the Literature
por: Ahmad, Shaharyar, et al.
Publicado: (2017)

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)

Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
por: Hirata, Masanori, et al.
Publicado: (2022)

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
por: Michalet, Morgan, et al.
Publicado: (2022)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
por: Jiang, Xue-song, et al.
Publicado: (2012)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7m06jnbq8gl363ck776fbs2945